# HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-da-22-034-heal-initiative-planning-grants-for-efficacy-or/  
Official notice: https://www.grants.gov/search-results-detail/337170

> National Institutes of Health offered grants of up to $600,000 to small businesses. Applications closed on March 10, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-DA-22-034 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | March 10, 2022 |
| Award ceiling | $600,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.213, 93.273, 93.279, 93.846, 93.866 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) encourages pilot and preliminary research to prepare for rigorous clinical efficacy or effectiveness trials of recovery support services for individuals who take or have taken medications for opioid use disorder (MOUDs). Relevant trials may test a wide range of services where rigorous evidence of efficacy and effectiveness are needed including peer-based recovery support, recovery community centers, active recovery communities, recovery residences, education-based recovery support services, continuing care models, recovery support services to meet the needs of specific minority health populations, recovery support services to meet the needs of specific health disparities populations, combinations of these recovery support services, or others proposed by applicants.

## Questions people ask

### Is RFA-DA-22-034 still open?

No. It closed on March 10, 2022.

### Who can apply for HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional)?

Closed March 10, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $600,000 each.

### Who has been funded under RFA-DA-22-034?

NIH RePORTER lists 3 projects funded under RFA-DA-22-034 in fiscal 2022 to 2025, at 3 institutions. The most were at Massachusetts General Hospital, Clemson University, Maryland Treatment Centers, Inc.

### Who has won Research and Training in Complementary and Integrative Health grants before?

The largest recipients over five fiscal years were Yale Univ, The General Hospital Corporation, Duke University. The program made 653 awards worth $575 million in that time.